open access

Vol 67, No 3 (2017)
Research paper (original)
Published online: 2017-12-12
Get Citation

Have actual waiting times been reduced by introducing the DILO reform for cancer patients in Poland?

Karolina Osowiecka12, Monika Rucińska, Sergiusz Nawrocki
·
Nowotwory. Journal of Oncology 2017;67(3):168-173.
Affiliations
  1. Department of Radiation Oncology, Hospital of the Ministry of Internal Affairs with Warmia and Mazury Oncology Center Olsztyn, Poland
  2. Department of Public Health, University of Warmia and Mazury, Olsztyn, Poland

open access

Vol 67, No 3 (2017)
Original article
Published online: 2017-12-12

Abstract

Introduction. Relative 5-year cancer survival rates in Poland are around 10% lower than the average of the whole EU. One of the likely factors for poorer treatment outcomes in Poland may be the long times between when cancer is suspected to starting treatment. This study has thus aimed to determine whether the introduced oncology reforms have succeeded in reducing such times.

Materials and methods. The study survey was undertaken at 6 oncological centres on patient subjects before (n = 1373) and after (n = 431) the oncological reform (DILO) had been introduced. Data was obtained from an in-house devised questionnaire together with patient interview and their medical history. The following waiting times were estimated: A) from suspicion of cancer, (date of first doctor visit due to appearance of symptoms, screening/follow-up or prevention), to diagnosis (date of histopathological confirmation), B) from suspicion of cancer to the start of treatment and C) from diagnosis to starting treatment before and after the DILO reform had been introduced.

Results. The median waiting time between suspicion of cancer and treatment was 11 weeks before the DILO reform but was not significantly shortened after its introduction; the reduction being barely 3 days. This waiting time was however increased by 8 days in those patients without DILO cards. Before the DILO reform, the median time from diagnosis was 5.9 weeks, but was reduced by 8 days in patients bearing the DILO card and indeed increased in those without the DILO card by over 2 weeks.

Conclusions. Cancer treatment waiting times in Poland is still somewhat long (over 9 weeks in most cases). Introducing the oncological reform has not significantly impacted on shortening the waiting times in cancer patients for receiving oncological treatment.

Abstract

Introduction. Relative 5-year cancer survival rates in Poland are around 10% lower than the average of the whole EU. One of the likely factors for poorer treatment outcomes in Poland may be the long times between when cancer is suspected to starting treatment. This study has thus aimed to determine whether the introduced oncology reforms have succeeded in reducing such times.

Materials and methods. The study survey was undertaken at 6 oncological centres on patient subjects before (n = 1373) and after (n = 431) the oncological reform (DILO) had been introduced. Data was obtained from an in-house devised questionnaire together with patient interview and their medical history. The following waiting times were estimated: A) from suspicion of cancer, (date of first doctor visit due to appearance of symptoms, screening/follow-up or prevention), to diagnosis (date of histopathological confirmation), B) from suspicion of cancer to the start of treatment and C) from diagnosis to starting treatment before and after the DILO reform had been introduced.

Results. The median waiting time between suspicion of cancer and treatment was 11 weeks before the DILO reform but was not significantly shortened after its introduction; the reduction being barely 3 days. This waiting time was however increased by 8 days in those patients without DILO cards. Before the DILO reform, the median time from diagnosis was 5.9 weeks, but was reduced by 8 days in patients bearing the DILO card and indeed increased in those without the DILO card by over 2 weeks.

Conclusions. Cancer treatment waiting times in Poland is still somewhat long (over 9 weeks in most cases). Introducing the oncological reform has not significantly impacted on shortening the waiting times in cancer patients for receiving oncological treatment.

Get Citation

Keywords

cancer, waiting time, diagnosis, health services, DILO reform

About this article
Title

Have actual waiting times been reduced by introducing the DILO reform for cancer patients in Poland?

Journal

Nowotwory. Journal of Oncology

Issue

Vol 67, No 3 (2017)

Article type

Research paper (original)

Pages

168-173

Published online

2017-12-12

Page views

706

Article views/downloads

831

DOI

10.5603/NJO.2017.0028

Bibliographic record

Nowotwory. Journal of Oncology 2017;67(3):168-173.

Keywords

cancer
waiting time
diagnosis
health services
DILO reform

Authors

Karolina Osowiecka
Monika Rucińska
Sergiusz Nawrocki

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl